Log in

OTCMKTS:RBGLYRECKITT BENCKIS/S Stock Price, Forecast & News

$18.85
+0.27 (+1.45 %)
(As of 07/3/2020 10:35 AM ET)
Add
Compare
Today's Range
$18.75
Now: $18.85
$18.88
50-Day Range
$17.20
MA: $17.66
$18.59
52-Week Range
$12.76
Now: $18.85
$18.88
Volume348,956 shs
Average Volume372,198 shs
Market Capitalization$66.86 billion
P/E Ratio20.94
Dividend Yield2.54%
Beta0.71
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names. It also provides hygienic products, including lavatory care products, antiseptic personal care products, pest control products, automatic dishwashing products, and depilatory products under the Bang, Clearasil, Dettol, Finish, Harpic, Lysol, Mortein, and Veet brand names. In addition, the company offers home products, such as fabric treatment products, water softeners, and air care products under the Air Wick, Calgon, Vanish, Woolite brands. Further, it provides infant and child nutrition products under the Enfamil and Nutramigen brands. The company operates in Europe, Russia, the CIS, Israel, North America, Australia, New Zealand, North Africa, the Middle East, Turkey, Africa, South Asia, North Asia, Latin America, Japan, South Korea, and ASEAN countries. Reckitt Benckiser Group plc was founded in 1823 and is headquartered in Slough, the United Kingdom.
Read More
RECKITT BENCKIS/S logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Soap & other detergents
Sub-IndustryN/A
Current SymbolOTCMKTS:RBGLY
Previous SymbolOTCMKTS:RBGPY
CUSIPN/A
CIKN/A
Phone01753217800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$16.55 billion
Cash Flow$2.94 per share
Book Value$3.39 per share

Profitability

Miscellaneous

Employees37,756
Outstanding Shares3,547,040,000
Market Cap$66.86 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive RBGLY News and Ratings via Email

Sign-up to receive the latest news and ratings for RBGLY and its competitors with MarketBeat's FREE daily newsletter.

RECKITT BENCKIS/S (OTCMKTS:RBGLY) Frequently Asked Questions

How has RECKITT BENCKIS/S's stock been impacted by COVID-19 (Coronavirus)?

RECKITT BENCKIS/S's stock was trading at $15.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RBGLY stock has increased by 24.7% and is now trading at $18.85. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of RECKITT BENCKIS/S?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RECKITT BENCKIS/S in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for RECKITT BENCKIS/S.

How often does RECKITT BENCKIS/S pay dividends? What is the dividend yield for RECKITT BENCKIS/S?

RECKITT BENCKIS/S announced a Semi-Annual dividend on Tuesday, April 14th. Stockholders of record on Friday, April 17th will be paid a dividend of $0.24 per share on Thursday, June 4th. The ex-dividend date of this dividend is Thursday, April 16th. View RECKITT BENCKIS/S's dividend history.

Has RECKITT BENCKIS/S been receiving favorable news coverage?

News articles about RBGLY stock have been trending negative on Friday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. RECKITT BENCKIS/S earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about RECKITT BENCKIS/S.

Who are some of RECKITT BENCKIS/S's key competitors?

Who are RECKITT BENCKIS/S's key executives?

RECKITT BENCKIS/S's management team includes the following people:
  • Mr. Rakesh Kapoor, Group CEO & Director (Age 60)
  • Mr. Adrian Nevil Hennah, CFO & Director (Age 62)
  • Mr. Aditya Sehgal, Chief Operating Officer of Health
  • Mr. Seth Cohen, Chief Information Officer
  • Mr. Richard Joyce, Sr. VP of Investor Relations

What is RECKITT BENCKIS/S's stock symbol?

RECKITT BENCKIS/S trades on the OTCMKTS under the ticker symbol "RBGLY."

How do I buy shares of RECKITT BENCKIS/S?

Shares of RBGLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RECKITT BENCKIS/S's stock price today?

One share of RBGLY stock can currently be purchased for approximately $18.85.

How big of a company is RECKITT BENCKIS/S?

RECKITT BENCKIS/S has a market capitalization of $66.86 billion and generates $16.55 billion in revenue each year. The company earns $-4,702,820,000.00 in net income (profit) each year or $0.90 on an earnings per share basis. RECKITT BENCKIS/S employs 37,756 workers across the globe.

What is RECKITT BENCKIS/S's official website?

The official website for RECKITT BENCKIS/S is www.rb.com.

How can I contact RECKITT BENCKIS/S?

RECKITT BENCKIS/S's mailing address is 103-105 BATH ROAD, SLOUGH X0, SL1 3UH. The company can be reached via phone at 01753217800 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.